The intravascular imaging market is projected to be valued US$ 387.8 million by 2023. By 2033, the market is projected to be valued US$ 656.29 million. The market is anticipated to develop at a compound annual growth rate (CAGR) of 5.4% between 2023 and 2033.
Over the projected period, further technological innovation, especially AI-enhanced imaging, is likely to drive market expansion. Prospects for growth may arise in developing nations with expanding healthcare infrastructure. The world’s ageing population may raise the demand for intravascular imaging, especially for personalized medicine applications.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9926
Regulation modifications will continue to have a significant impact on market dynamics and the rate of technological adoption. The intravascular imaging market is expected to evolve significantly between 2023 and 2033, driven by technological advancements and altering healthcare requirements.
The increasing demand for intravascular imaging is also being pushed by institutional and office-based physician efforts to reduce healthcare costs. The drive towards downsizing, adaptability, and inexpensiveness has influenced the increasing usage of intravascular imaging systems.
The continuing efforts of companies to manufacture technologically advanced diagnostic equipment are expected to fuel intravascular imaging sales and contribute to the intravascular imaging market share growth. Globally rising rates of deep vein thrombosis, heart disease with coronary occlusion, and other disorders are expected to increase patient traffic in diagnostic centers, fueling intravascular imaging market development.
Key Takeaways:
- The United States is predicted to reach US$ 700 million by 2033.
- The United States is predicted to increase at a 5.6% annual rate.
- The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.
- China’s intravascular imaging industry is anticipated to be worthUS$850 million.
- The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.
“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.
Intravascular Imaging Market Competitive Landscape
The major companies in the intravascular imaging market are attempting to expand their product footprint in order to strengthen their global sales chances. Collaborations, mergers and acquisitions, and agreements between regional and global market leaders are also expected to increase intravascular imaging market share.
- Siemens Healthineers launched Luminos Impulse, a fluoroscopy technology with a cutting-edge layout and characteristics shared by high-end fluoroscopy systems including an intuitive imaging chain, complete dose optimization, cybersecurity attributes, and detector-sharing capacity for radiography, in September 2021.
- In May 2021, Siemens Healthineers launched Somatom X.ceed, a one-of-a-kind high-resolution, fast-paced CT (computed tomography) scanner intended exclusively for exceptionally demanding medical uses where time and precision are important.
Key Players :
- Acqiris
- NIDEK CO. LTD.
- AGFA Healthcare
- Aculight Carl Zeiss AG
- Heidelberg Engineering Inc.
- Optopol
- Sonostar Technologies Co.Ltd.
- OPKO Health
- AlazarTech
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9926
Segmentation Analysis of the Intravascular Imaging Market
By Product Type:
- Instruments
- Software
By Modality:
- Handheld
- Trolley Mounted
By End User:
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Long Term Care Centers
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube